Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2007
10/18/2007CA2638864A1 Truncated il-17ra soluble receptor and methods of using in inflammation
10/17/2007EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007EP1845104A1 Par-2 agonist
10/17/2007EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
10/17/2007EP1844767A2 Epoxide hydrolase complexes and methods therewith
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1844336A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
10/17/2007EP1844054A2 Thiazolopyrimidine compounds for the modulation of chemokine receptor activity
10/17/2007EP1844053A2 Anti-inflammatory macrolide conjugates
10/17/2007EP1844051A1 Thienopyrroles useful in the treatment of inflammation
10/17/2007EP1844040A1 Crystalline forms of cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido)cyclohexyl]-2-(tetrahydrothiopyran-4-yloxy)nicotinamide
10/17/2007EP1844039A1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
10/17/2007EP1844032A1 N-hydroxyamide derivatives and use thereof
10/17/2007EP1844013A1 Indoles useful in the treatment of inflammation
10/17/2007EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
10/17/2007EP1608349B1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
10/17/2007EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1225882B1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007CN101056672A Process for {3-[2(R)-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl]ethoxy]-3(S)-(4-fluorophenyl) morpholin-4-yl}-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
10/17/2007CN101056634A Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
10/17/2007CN101054364A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (ER) ligands and their use in the treatmentof inflammarory diseases
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053662A Nonsteroidal antiinflammatories with nitric oxide donors and its preparation method
10/17/2007CN101053633A Medicinal composition for treating rheumatalgia pain
10/17/2007CN101053623A Medicinal composition for treating pain and preparation technology thereof
10/17/2007CN101053603A Fupo cold granules and preparation method thereof
10/17/2007CN101053599A Compound oral preparation composition for treating wound and pain and preparing products method thereof
10/17/2007CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007CN101053554A Ginkgolide B powder injection and its preparation method
10/17/2007CN101053421A Radish abalone soup
10/17/2007CN101053408A Preparation method for pepper food additive containing purging fire factor
10/17/2007CN101053386A 糯米保健粥 Glutinous rice porridge health
10/17/2007CN101053361A Honeysuckle and forsythia driving away summer tea
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/17/2007CN100343254C Pyrrolopyrimidine derivatives
10/17/2007CN100343249C 2,4,4-trisubstituted-1,3-dioxolane antifungals
10/17/2007CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/17/2007CN100342899C Fragrants medicated liquor for treating fractures
10/17/2007CN100342898C Zhulan medicated liquor
10/17/2007CN100342897C Chinese-yeast-hops medicated liquor
10/17/2007CN100342886C Medicated liquor of Radix elsholtziae Fruticosae
10/17/2007CN100342885C Medicated liquor of Herba Tetrastigmae Yunnanensis
10/17/2007CN100342884C Medicated liquor of Radix Tetrastigmatis Hypoglauci
10/17/2007CN100342883C Compound essence oil for curing arthralgia and myalgia of human
10/17/2007CN100342866C Tuqiannianjian medicated liquor
10/17/2007CN100342862C Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof
10/17/2007CN100342848C Effervescence tablet for reducing fever comprising tropaeolum and process for preparing the same
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/13/2007CA2566832A1 Cyclised alpha-conotoxin peptides
10/11/2007WO2007114827A1 Substituted heterocyclic compounds and methods of use
10/11/2007WO2007114763A1 Sulphonamide derivates as modulators of the glucocorticoid receptor
10/11/2007WO2007114262A1 Casein nanoparticle
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007112968A2 Anti-inflammatory polymer
10/11/2007WO2007112492A1 Compounds and methods for the treatment of pain
10/11/2007WO2007075901A3 Quinolin- 4 - one derivatives as modulators of abc transporters
10/11/2007WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007WO2007057714A3 Pharmaceutical compositions comprising methotrexate
10/11/2007WO2006072823A3 Brachystemma calycinum preparation for joint pain
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238875 Heterocyclic compounds
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238749 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
10/11/2007US20070238743 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
10/11/2007US20070238736 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-[4-(Benzo [1,3]dioxole-5-carbonyl)-piperazin-1-yl]-1-(4-fluoro-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238708 Acute Inflammatory Condition Treatment
10/11/2007US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070237848 MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2648443A1 Substituted heterocyclic compounds and methods of use
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842851A2 Novel compounds
10/10/2007EP1842545A1 Anti-inflammatory polymer
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
1 ... 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 ... 1272